短期与长期心智化治疗对阈下或确诊边缘型人格障碍门诊患者的随机临床试验方案
该试验为研究者发起的单中心随机临床优效性试验,比较短期(20周)与长期(14个月)心智化治疗对阈下或确诊边缘型人格障碍门诊患者的疗效。主要结局为Zanarini边缘型人格障碍评定量表评估的边缘型症状严重程度,随访至随机化后24个月。
要点
- 试验比较短期(20周)与长期(14个月)心智化治疗对边缘型人格障碍门诊患者的疗效。
- 主要结局为Zanarini边缘型人格障碍评定量表评估的边缘型症状严重程度。
- 次要结局包括自伤事件、功能损害和生活质量,随访至随机化后24个月。
核心结论
- 该试验将提供短期与长期心智化治疗对阈下或确诊边缘型人格障碍门诊患者有益和有害效应的证据。
研究设计与样本
- 研究者发起的单中心随机临床优效性试验,比较短期(20周)与长期(14个月)心智化治疗。
- 受试者为来自丹麦首都大区心理健康服务Stolpegaard心理治疗中心人格障碍门诊的阈下或确诊边缘型人格障碍门诊患者。
- 纳入标准为满足至少4条DSM-V边缘型人格障碍诊断标准。
- 在随机化前以及随机化后8、16和24个月进行评估。
关键数值与推荐
- 主要结局为Zanarini边缘型人格障碍评定量表评估的边缘型症状严重程度。
- 次要结局包括自伤事件、功能损害(工作与社会适应量表、全球功能评估)和生活质量(36项简式健康调查)。
- 精神症状严重程度(症状自评量表90-R)作为探索性结局。
- 人格功能、依恋、边缘型症状、团体联盟和心智化技能等测量用于探索潜在预测因素和变化机制。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Psychotherapy for borderline personality disorder is often lengthy and resource-intensive. However, the current length of outpatient treatments is arbitrary and based on trials that never tested if the treatment intensity could be reduced. As a result, there is insufficient evidence to inform the decision between short-term and long-term psychotherapy for borderline personality disorder. Mentalization-based therapy is one treatment option for borderline personality disorder and consists traditionally of an 18-month treatment program. METHODS/DESIGN: This trial is an investigator-initiated single-center randomized clinical superiority trial of short-term (20 weeks) compared to long-term (14 months) mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder. Participants will be recruited from the Outpatient Clinic for Personality Disorders at Stolpegaard Psychotherapy Centre, Mental Health Services, Capital Region of Denmark. Participants will be included if they meet a minimum of four DSM-V criteria for borderline personality disorder. Participants will be assessed before randomization, and at 8, 16, and 24 months after randomization. The primary outcome is severity of borderline symptomatology assessed with the Zanarini Rating Scale for borderline personality disorder. Secondary outcomes include self-harm incidents, functional impairment (Work and Social Adjustment Scale, Global Assessment of Functioning) and quality of life (Short-Form Health Survey 36). Severity of psychiatric symptoms (Symptom Checklist 90-R) will be included as an exploratory outcome. Measures of personality functioning, attachment, borderline symptoms, group alliance, and mentalization skills will be included to explore potential predictors and mechanisms of change. DISCUSSION: This trial will provide evidence of the beneficial and harmful effects of short-term compared to long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03677037 . Registered on September 19, 2018.
引用
- Juul S, Lunn S, Poulsen S, et al. Short-term versus long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trial. Trials. 2019. PMID: 30953536. doi:10.1186/s13063-019-3306-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。